1228 Real-world direct healthcare costs for metastatic colorectal cancer patients treated with cetuximab vs. bevacizumab containing regimen in first-line, or sequentially in first- and second-line, from a US private payer perspective

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 51; p. S182
Main Authors Johnston, S, Wilson, K, Riehle, E, Varker, H, Juneau, P, Sommer, N, Ogale, S
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2015
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)30532-9